Beijing Bohui Innovation Technology Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.16%

Beijing Bohui Innovation Technology Co Ltd (300318) has an Asset Resilience Ratio of 0.16% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Beijing Bohui Innovation Technology Co L balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥6.98 Million
≈ $1.02 Million USD Cash + Short-term Investments

Total Assets

CN¥4.33 Billion
≈ $632.97 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2005–2023)

This chart shows how Beijing Bohui Innovation Technology Co Ltd's Asset Resilience Ratio has changed over time. See Beijing Bohui Innovation Technology Co L (300318) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Beijing Bohui Innovation Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Beijing Bohui Innovation Technology Co L (300318) market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥6.98 Million 0.16%
Total Liquid Assets CN¥6.98 Million 0.16%

Asset Resilience Insights

  • Limited Liquidity: Beijing Bohui Innovation Technology Co Ltd maintains only 0.16% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Beijing Bohui Innovation Technology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Bohui Innovation Technology Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Argen-X
F:1AE
Biotechnology 25.67%
Tubize-Fin
BR:TUB
Biotechnology 0.05%
BrightGene Bio Medical Technology C
SHG:688166
Biotechnology 1.00%
Dashenlin Pharm Grp Co Ltd
SHG:603233
Biotechnology 0.02%
Staidson Beijing Biopharma
SHE:300204
Biotechnology 7.93%
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287
Biotechnology 41.25%
Ardelyx Inc
NASDAQ:ARDX
Biotechnology 41.14%
Xiangxue Pharmaceutical
SHE:300147
Biotechnology 0.05%

Annual Asset Resilience Ratio for Beijing Bohui Innovation Technology Co Ltd (2005–2023)

The table below shows the annual Asset Resilience Ratio data for Beijing Bohui Innovation Technology Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 -4.12% CN¥-161.72 Million
≈ $-23.66 Million
CN¥3.93 Billion
≈ $574.50 Million
+1.35pp
2022-12-31 -5.47% CN¥-213.82 Million
≈ $-31.29 Million
CN¥3.91 Billion
≈ $571.86 Million
-1.69pp
2021-12-31 -3.78% CN¥-139.46 Million
≈ $-20.41 Million
CN¥3.69 Billion
≈ $539.97 Million
-1.75pp
2020-12-31 -2.03% CN¥-75.57 Million
≈ $-11.06 Million
CN¥3.72 Billion
≈ $543.66 Million
+0.40pp
2019-12-31 -2.43% CN¥-65.48 Million
≈ $-9.58 Million
CN¥2.69 Billion
≈ $394.31 Million
-0.12pp
2018-12-31 -2.31% CN¥-62.63 Million
≈ $-9.17 Million
CN¥2.71 Billion
≈ $396.90 Million
-2.49pp
2017-12-31 0.19% CN¥5.07 Million
≈ $742.31K
CN¥2.74 Billion
≈ $400.58 Million
-45.78pp
2007-12-31 45.97% CN¥48.73 Million
≈ $7.13 Million
CN¥106.00 Million
≈ $15.51 Million
+42.99pp
2006-12-31 2.98% CN¥2.40 Million
≈ $351.20K
CN¥80.53 Million
≈ $11.78 Million
-56.27pp
2005-12-31 59.25% CN¥45.10 Million
≈ $6.60 Million
CN¥76.12 Million
≈ $11.14 Million
--
pp = percentage points

About Beijing Bohui Innovation Technology Co Ltd

SHE:300318 China Biotechnology
Market Cap
$669.41 Million
CN¥4.57 Billion CNY
Market Cap Rank
#11067 Global
#3292 in China
Share Price
CN¥5.60
Change (1 day)
-0.53%
52-Week Range
CN¥5.51 - CN¥8.17
All Time High
CN¥21.16
About

Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; albumin; human prothrombin complex; and vaccine for rabies. It also provides molecular platform, such as Automatic Real-time Fl… Read more